FindMyRecallSubscribe
Class III: unlikely to cause harmTerminated

Valeant Pharmaceuticals International Hydrocortisone Butyrate Cream 0 Recall

Hydrocortisone Butyrate Cream 0

Valeant Pharmaceuticals International · Bridgewater, NJ

Risk level
Class III
Reported by FDA
Oct 22, 2014
Recall ID
D-0025-2015
Check your lot numberHow we source this data

Summary

Valeant Pharmaceuticals International recalled Hydrocortisone Butyrate Cream 0 starting Oct 2, 2014. The FDA classified it as Class III (unlikely to cause harm) and published enforcement report D-0025-2015 on Oct 22, 2014. Reason: Subpotent Drug; for the active, HCB, and preservatives, Propylparaben and Butylparaben at the 18 month stability test point. Status: Terminated.

Why it was recalled

Subpotent Drug; for the active, HCB, and preservatives, Propylparaben and Butylparaben at the 18 month stability test point

Product description

Hydrocortisone Butyrate Cream 0.1%, Net Wt. 15 gm tubes, Rx only, Manufactured for: Rouses Point Pharmaceuticals, LLC Cranford, NJ 07016 By: Ferndale Laboratories, Inc. Ferndale, MI 48220 --- NDC 43478-270-15

Lot numbers, UPCs & expiration codes

Lot numbers 13052C, exp 03/2015 and 13156A, exp 08/2015, NDC 43478-270-15

Where it was sold

Nationwide and Puerto Rico

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0025-2015
Classification
Class III
Status
Terminated
Recall initiated
Oct 2, 2014
FDA report date
Oct 22, 2014
Quantity
34,218 tubes
Recall type
Voluntary: Firm initiated
Recalling firm
Valeant Pharmaceuticals International

Original FDA data

Every field from FDA enforcement report D-0025-2015, exactly as published.

Show all FDA fields
City
Bridgewater
State
NJ
Status
Terminated
Country
United States
Event ID
69359
Address
400 Somerset Corporate Blvd
Code information
Lot numbers 13052C, exp 03/2015 and 13156A, exp 08/2015, NDC 43478-270-15
Postal code
08807-2867
Report date
Oct 22, 2014
Product type
Drugs
Recall number
D-0025-2015
Classification
Class III
Recalling firm
Valeant Pharmaceuticals International
Product quantity
34,218 tubes
Termination date
Apr 3, 2015
Reason for recall
Subpotent Drug; for the active, HCB, and preservatives, Propylparaben and Butylparaben at the 18 month stability test point
Voluntary / mandated
Voluntary: Firm initiated
Product description
Hydrocortisone Butyrate Cream 0.1%, Net Wt. 15 gm tubes, Rx only, Manufactured for: Rouses Point Pharmaceuticals, LLC Cranford, NJ 07016 By: Ferndale Laboratories, Inc. Ferndale, MI 48220 --- NDC 43478-270-15
Distribution pattern
Nationwide and Puerto Rico
Recall initiation date
Oct 2, 2014
Initial firm notification
Letter
Center classification date
Oct 16, 2014

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0025-2015, published Oct 22, 2014. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls